Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Big stage for diabetes hopeful

Friday, August 28th, 2009

Recent regulatory setbacks aside, Takeda Pharmaceutical Co. is plowing full steam ahead on its quest to win approval for the company’s key type 2 diabetes drug alogliptin, another potential entrant into the suddenly competitive field of DPP-4 inhibitors. The Japanese drug giant said today that it received the “all-clear” from FDA ...

Posted in CRO, Uncategorized, clinical trials, diabetes, filed for approval | No Comments »

Diabetes studies offer cancer clues

Thursday, June 4th, 2009

Researchers have made a breakthrough that may increase the efficiency of vaccines and cancer treatments. They discovered that diabetes drug metformin can increase T-cell’s in the body’s immune system and since T-cells can remember pathogens they have encountered from past infections of vaccinations they can fight infections faster. Diabetes therapies are ...

Posted in cancer, diabetes, vaccines | No Comments »

Warning: may cure diabetes

Friday, March 20th, 2009

We've talked a lot about animals in our visit to Old MacDonald's Pharma, but there's some fascinating things going on out in the fields as well. According to Reuters, European scientists have discovered that breeding genetically modified tobacco plants containing interleukin-10 (IL-10) anti-inflammatory protein may help patients with type 1 diabetes ...

Posted in diabetes, molecular farming, plants | No Comments »

   
about us | advertise | contact us | home
terms of use | privacy | copyright | site map 		©2012 UBM Canon